Nu Skin Enterprises, Inc. (NUS) stock
NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3069% below fair value
$4.01+0.12 (+3.08%)
Close on Nov 12, 2026Market cap $195.19MP/E –Yield –
Nu Skin Enterprises operating margin
Operating margin is operating income as a percentage of revenue.
Nu Skin Enterprises's operating margin for the twelve months ending Sep 30, 2026 was -2.0%. For fiscal 2025 it was 4.4%, against -8.8% the year before. The highest annual figure on record is 17.4% in fiscal 2013.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.4% | +13.2 |
| FY2024 | Dec 31, 2024 | -8.8% | −11.2 |
| FY2023 | Dec 31, 2023 | 2.5% | −2.5 |
| FY2022 | Dec 31, 2022 | 5.0% | −3.7 |
| FY2021 | Dec 31, 2021 | 8.7% | −1.3 |
| FY2020 | Dec 31, 2020 | 10.0% | −1.1 |
| FY2019 | Dec 31, 2019 | 11.0% | +2.1 |
| FY2018 | Dec 31, 2018 | 9.0% | −3.1 |
| FY2017 | Dec 31, 2017 | 12.0% | +1.6 |
| FY2016 | Dec 31, 2016 | 10.5% | −0.4 |
| FY2015 | Dec 31, 2015 | 10.9% | −2.8 |
| FY2014 | Dec 31, 2014 | 13.7% | −3.7 |
| FY2013 | Dec 31, 2013 | 17.4% | +1.5 |
| FY2012 | Dec 31, 2012 | 16.0% | +2.4 |
| FY2011 | Dec 31, 2011 | 13.6% | −0.5 |
| FY2010 | Dec 31, 2010 | 14.1% | +3.0 |
| FY2009 | Dec 31, 2009 | 11.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 1.6% | −4.3 |
| Q2 FY2026 | Jun 30, 2026 | -18.5% | −26.5 |
| Q1 FY2026 | Mar 31, 2026 | 1.3% | +4.0 |
| Q4 FY2025 | Dec 31, 2025 | 6.3% | +18.2 |
| Q3 FY2025 | Sep 30, 2025 | 5.9% | +1.7 |
| Q2 FY2025 | Jun 30, 2025 | 8.0% | +36.6 |
| Q1 FY2025 | Mar 31, 2025 | -2.7% | −4.8 |
| Q4 FY2024 | Dec 31, 2024 | -11.9% | −15.2 |
| Q3 FY2024 | Sep 30, 2024 | 4.2% | +9.5 |
| Q2 FY2024 | Jun 30, 2024 | -28.6% | −37.1 |
| Q1 FY2024 | Mar 31, 2024 | 2.1% | −1.2 |
| Q4 FY2023 | Dec 31, 2023 | 3.3% | −2.0 |
| Q3 FY2023 | Sep 30, 2023 | -5.3% | −1.5 |
| Q2 FY2023 | Jun 30, 2023 | 8.5% | −0.7 |
| Q1 FY2023 | Mar 31, 2023 | 3.3% | −5.3 |
| Q4 FY2022 | Dec 31, 2022 | 5.3% | +2.2 |
| Q3 FY2022 | Sep 30, 2022 | -3.8% | −14.0 |
| Q2 FY2022 | Jun 30, 2022 | 9.2% | −2.9 |
| Q1 FY2022 | Mar 31, 2022 | 8.6% | −0.7 |
| Q4 FY2021 | Dec 31, 2021 | 3.0% | −8.8 |
| Q3 FY2021 | Sep 30, 2021 | 10.2% | −0.4 |
| Q2 FY2021 | Jun 30, 2021 | 12.1% | +2.6 |
| Q1 FY2021 | Mar 31, 2021 | 9.3% | +2.2 |
| Q4 FY2020 | Dec 31, 2020 | 11.9% | +2.5 |
| Q3 FY2020 | Sep 30, 2020 | 10.6% | −1.3 |
| Q2 FY2020 | Jun 30, 2020 | 9.5% | −2.4 |
| Q1 FY2020 | Mar 31, 2020 | 7.1% | −4.0 |
| Q4 FY2019 | Dec 31, 2019 | 9.4% | +6.7 |
| Q3 FY2019 | Sep 30, 2019 | 11.8% | −0.1 |
| Q2 FY2019 | Jun 30, 2019 | 11.9% | +0.1 |
| Q1 FY2019 | Mar 31, 2019 | 11.0% | +1.4 |
| Q4 FY2018 | Dec 31, 2018 | 2.7% | −12.2 |
| Q3 FY2018 | Sep 30, 2018 | 11.9% | +0.5 |
| Q2 FY2018 | Jun 30, 2018 | 11.8% | −0.0 |
| Q1 FY2018 | Mar 31, 2018 | 9.6% | +0.3 |
| Q4 FY2017 | Dec 31, 2017 | 14.9% | +3.4 |
| Q3 FY2017 | Sep 30, 2017 | 11.4% | – |
| Q2 FY2017 | Jun 30, 2017 | 11.8% | – |
| Q1 FY2017 | Mar 31, 2017 | 9.3% | – |
| Q4 FY2016 | Dec 31, 2016 | 11.4% | – |
See a number that looks wrong?